Incorporation of tumor-targeting peptides into recombinant Adeno-associated virus capsids
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Molecular Therapy, 3, 6, S. 964-975
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg, Amsterdam [u.a.]
- (wer)
-
Universität Augsburg, Elsevier
- (wann)
-
2001
- Urheber
-
Grifman, Mirta
Trepel, Martin
Speece, Paul
Gilbert, Luz Beatriz
Arap, Wadih
Pasqualini, Renata
Weitzman, Matthew D.
- DOI
-
10.1006/mthe.2001.0345
- URN
-
urn:nbn:de:bvb:384-opus4-723329
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grifman, Mirta
- Trepel, Martin
- Speece, Paul
- Gilbert, Luz Beatriz
- Arap, Wadih
- Pasqualini, Renata
- Weitzman, Matthew D.
- Universität Augsburg, Elsevier
Entstanden
- 2001
Ähnliche Objekte (12)
EGFR-binding peptides: from computational design towards tumor-targeting of adeno-associated virus capsids
Expanding the potential of cell-penetrating peptides via the incorporation of different targeting moities
Peptides targeting caspase inhibitors
Vascular-targeted recombinant adeno-associated viral vectors for the treatment of rare diseases
Targeting of RNA-binding proteins with macrocyclic peptides
Tumor targeting peptides - neuropeptide y based shuttle systems
Immunological targeting and cellular entry of adeno-associated virus type 2
Recombinant adeno-associated virus-based vectors for gene therapy : novel strategies towards improved manufacturing
Generation and characterization of recombinant cell penetrating peptides for siRNA delivery
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting RNA-Protein interactions with peptides and small molecule inhibitors
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
EGFR-binding peptides: from computational design towards tumor-targeting of adeno-associated virus capsids
Expanding the potential of cell-penetrating peptides via the incorporation of different targeting moities
Peptides targeting caspase inhibitors
Vascular-targeted recombinant adeno-associated viral vectors for the treatment of rare diseases
Targeting of RNA-binding proteins with macrocyclic peptides
Tumor targeting peptides - neuropeptide y based shuttle systems
Immunological targeting and cellular entry of adeno-associated virus type 2
Recombinant adeno-associated virus-based vectors for gene therapy : novel strategies towards improved manufacturing
Generation and characterization of recombinant cell penetrating peptides for siRNA delivery
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting RNA-Protein interactions with peptides and small molecule inhibitors
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
EGFR-binding peptides: from computational design towards tumor-targeting of adeno-associated virus capsids
Expanding the potential of cell-penetrating peptides via the incorporation of different targeting moities
Peptides targeting caspase inhibitors
Vascular-targeted recombinant adeno-associated viral vectors for the treatment of rare diseases
Targeting of RNA-binding proteins with macrocyclic peptides
Tumor targeting peptides - neuropeptide y based shuttle systems
Immunological targeting and cellular entry of adeno-associated virus type 2
Recombinant adeno-associated virus-based vectors for gene therapy : novel strategies towards improved manufacturing
Generation and characterization of recombinant cell penetrating peptides for siRNA delivery
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting RNA-Protein interactions with peptides and small molecule inhibitors